Literature DB >> 15273191

Objective evaluation of small bowel and colonic transit time using pH telemetry in athletes with gastrointestinal symptoms.

K A Rao1, E Yazaki, D F Evans, R Carbon.   

Abstract

BACKGROUND: Gastrointestinal (GI) disturbances are often reported by long distance runners and are more common in women, particularly after prolonged high intensity exercise.
OBJECTIVES: To determine whether these symptoms could be associated with alterations in GI motility.
METHODS: Small bowel and colonic transit were measured using pH telemetry in a group of 11 female athletes (age 22 to 53 years), six of whom experienced lower GI symptoms during exercise. Subjects participated in two experimental sessions: a control measurement, where small bowel transit was estimated during a rest period (R) of six hours; and an exercise session (E), where small bowel transit was measured during a one hour period of high intensity exercise (cross country running) at >70% VO(2)max. Colonic transit was estimated indirectly from determinations of whole gut transit time by radio-opaque marker.
RESULTS: Small bowel transit time was 3.5 to 10.6 h (R) and 3.0 to 8.7 h (E) in asymptomatic athletes, versus 4.0 to 6.6 h (R) and 4.6 to 7.3 h (E) in symptomatic athletes (NS). Colonic transit time was 35.0 to 62.5 h (R) and 30.5 to 70.9 h (E) in asymptomatic athletes versus 20.4 to 42.9 h (R) and 21.5 to 67.2 h (E) in symptomatic athletes (NS).
CONCLUSIONS: Small bowel and colonic transit times were similar in the two groups in the rest and exercise sessions. The diarrhoea seen in this study did not result from accelerated colonic transit. Other mechanisms must be sought.

Entities:  

Mesh:

Year:  2004        PMID: 15273191      PMCID: PMC1724875          DOI: 10.1136/bjsm.2003.006825

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  22 in total

Review 1.  Aetiology of running-related gastrointestinal dysfunction. How far is the finishing line?

Authors:  S M Gil; E Yazaki; D F Evans
Journal:  Sports Med       Date:  1998-12       Impact factor: 11.136

2.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

3.  The effects of an aerobic running program on bowel transit time.

Authors:  L Cordain; R W Latin; J J Behnke
Journal:  J Sports Med Phys Fitness       Date:  1986-03       Impact factor: 1.637

4.  A ne method for studying gut transit times using radioopaque markers.

Authors:  J M Hinton; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

5.  Relationship between postprandial motor activity in the human small intestine and the gastrointestinal transit of food.

Authors:  N W Read; M N Al-Janabi; C A Edwards; D C Barber
Journal:  Gastroenterology       Date:  1984-04       Impact factor: 22.682

6.  'Runner's trots'. Gastrointestinal disturbances in runners.

Authors:  R N Fogoros
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

7.  Segmental colonic transit time.

Authors:  P Arhan; G Devroede; B Jehannin; M Lanza; C Faverdin; C Dornic; B Persoz; L Tétreault; B Perey; D Pellerin
Journal:  Dis Colon Rectum       Date:  1981 Nov-Dec       Impact factor: 4.585

8.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

9.  Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine.

Authors:  J Cammack; N W Read; P A Cann; B Greenwood; A M Holgate
Journal:  Gut       Date:  1982-11       Impact factor: 23.059

10.  Breath hydrogen (H2) response to carbohydrate malabsorption after exercise.

Authors:  D L Payne; J D Welsh; P L Claypool
Journal:  J Lab Clin Med       Date:  1983-07
View more
  13 in total

Review 1.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

2.  Identification of Campylobacter jejuni genes contributing to acid adaptation by transcriptional profiling and genome-wide mutagenesis.

Authors:  Anne N Reid; Reenu Pandey; Kiran Palyada; Lisa Whitworth; Evgueni Doukhanine; Alain Stintzi
Journal:  Appl Environ Microbiol       Date:  2008-01-11       Impact factor: 4.792

Review 3.  Physical activity and the pelvic floor.

Authors:  Ingrid E Nygaard; Janet M Shaw
Journal:  Am J Obstet Gynecol       Date:  2015-09-06       Impact factor: 8.661

4.  Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: impact of a fitness and weight loss intervention.

Authors:  Dmitry Grapov; Oliver Fiehn; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Charles L Hoppel; Mary-Ellen Harper; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-17       Impact factor: 4.310

5.  Characterization of the biochemical properties of Campylobacter jejuni RNase III.

Authors:  Nabila Haddad; Margarida Saramago; Rute G Matos; Hervé Prévost; Cecília M Arraiano
Journal:  Biosci Rep       Date:  2013-11-25       Impact factor: 3.840

Review 6.  Gastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendations.

Authors:  Erick Prado de Oliveira; Roberto Carlos Burini; Asker Jeukendrup
Journal:  Sports Med       Date:  2014-05       Impact factor: 11.136

Review 7.  Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

Review 8.  Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

9.  Acid stress response and protein induction in Campylobacter jejuni isolates with different acid tolerance.

Authors:  Tina Birk; Monica Takamiya Wik; René Lametsch; Susanne Knøchel
Journal:  BMC Microbiol       Date:  2012-08-13       Impact factor: 3.605

Review 10.  New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.

Authors:  Adrian H Teruel; Isabel Gonzalez-Alvarez; Marival Bermejo; Virginia Merino; Maria Dolores Marcos; Felix Sancenon; Marta Gonzalez-Alvarez; Ramon Martinez-Mañez
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.